WOBURN, Mass., Nov. 01, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), announced today that the Company plans to release its third quarter 2016 financial results and host a conference call with management after market close on Wednesday, November 9, 2016.
While shareholders participate in the call in listen-only mode, the Company invites shareholders to submit questions by November 7, 2016 for consideration to [email protected] with the subject line: “Questions for Third Quarter Call.” Questions submitted in advance of the call will be reviewed and a certain number of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
U.S. Toll-free dial-in: 1-877-709-8150
International dial-in: 201-689-8354
Event Date/Time: Wednesday, Nov. 9 at 4:30 p.m. ET
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.metabolix.com. In addition, the webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial toll-free 877-660-6853 or 201-612-7415 (international) and enter pass code 13648037. The replay will be available for 14 days.
About Metabolix
Metabolix, Inc. is winding down its legacy PHA biopolymer business and becoming Yield10 Bioscience. Yield10 is leveraging Metabolix’s extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems with a focus on developing disruptive technologies for step-change improvements in crop yield. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing the development of several yield traits in crops such as camelina, canola, soybean and corn. The Company is based in Woburn, MA.
For more information, visit www.metabolix.com. (MBLX-E)
For more information on Yield10 Bioscience, visit Yield10.
Metabolix Contact: Lynne H. Brum, 617-682-4693, [email protected]


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Instagram Outage Disrupts Thousands of U.S. Users
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



